#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Langerhans cell sarcoma Colon cancer Synovial sarcoma metastatic Short-bowel syndrome Dermatitis Non-renal cell carcinoma of kidney Proteus syndrome Hypoparathyroidism Univentricular heart Myelin oligodendrocyte glycoprotein antibody-associated disease Vernal keratoconjunctivitis Ovarian cancer Hereditary motor and sensory neuropathy Head and neck cancer Neonatal asphyxia More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Life with Disease Ornithine transcarbamoylase deficiency – Treatment Fragile X syndrome – Trials in Disease Angiosarcoma non-metastatic – Life with Disease Focal segmental glomerulosclerosis – Basic Information Haemophilia A without inhibitors – Basic Information Breast angiosarcoma metastatic – Diagnostics Acquired haemophilia – Life with Disease Ewing’s sarcoma – Trials in Disease Antisynthetase syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clofazimine Medi0618 Abc-15Bo-116 Lutetium (177Lu) Edotreotide Mcla-129 Acetylcysteine Aflibercept Hydrochlorothiazide Eltrombopag Tetracaine Hydrochloride Siltuximab Cytisine Alnus Glutinosa Pollen Forimtamig Gad20-209-Fsp-A1 Rusfertide Resatorvid Iberdomide Gskvx000000008885 Fentanyl More therapies…

    Learn about Your Condition

    Cold type haemolytic anaemia Acromegaly Elderly Krabbe's disease Marfan's syndrome Tourette's disorder Indolent systemic mastocytosis Mesothelioma malignant Synovial sarcoma Hyperglycaemia Oral neoplasm Vulvovaginal pain Guttate psoriasis Myeloid leukaemia Ischaemic stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. KBC Zagreb

KBC Zagreb

Ulica Mije Kispatica 12, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Nacubactam
    • Tigecycline
    • Imipenem
    Croatia Czechia France Greece Latvia Slovakia +1

  • Study on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy

    Not recruiting

    4 1 1
    Belgium Croatia France Germany Italy The Netherlands +3

  • Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Irbesartan
    • Sparsentan
    • Dapagliflozin
    Belgium Croatia Czechia Estonia France Germany +5

  • Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Etrasimod Arginine
    Austria Belgium Bulgaria Croatia Czechia Denmark +9

  • Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

    Not recruiting

    3 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Bi 1015550
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    Austria Belgium Croatia Czechia Denmark Estonia +13

  • Study of Plozasiran for Adults with Severe Hypertriglyceridemia

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia Hungary Italy +4

  • Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Irbesartan
    • Sparsentan
    Belgium Croatia Czechia Denmark Estonia France +6

  • Study on the Effects of ARO-APOC3 for Adults with Familial Chylomicronemia Syndrome

    Not recruiting

    3 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Austria Belgium Croatia France Ireland Poland +1

  • Study on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1
    Investigated Drugs:
    • Obexelimab
    Austria Belgium Croatia Czechia Denmark Finland +4

  • Title: Comparing Brentuximab Vedotin plus ESHAP versus ESHAP alone in treating patients with relapsed or refractory classical Hodgkin’s Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Brentuximab Vedotin
    Austria Croatia Greece Spain
Previous Page
1 … 8 9 10 11 12 … 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!